AI assistant
STAR COMBO PHARMA LIMITED — Director's Dealing 2019
Aug 18, 2019
65746_rns_2019-08-18_5ca371aa-d552-4d31-8413-137ba4f0b9da.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Z Final Director’s Interest Notice
Rule 3.19A.3
Appendix 3Z
Final Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity: Star Combo Pharma Limited ABN: 38 615 728 375
We (the entity) give ASX the following information under listing rule 3.19A.3 and as agent for the director for the purposes of section 205G of the Corporations Act.
Name of director Craig Bottomley
Date of last notice 21 May 2018
Date that director ceased to be director 15 August 2019
Part 1 – Director’s relevant interests in securities of which the director is the registered holder
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
Number & class of securities
==> picture [28 x 12] intentionally omitted <==
----- Start of picture text ----- N/A----- End of picture text -----
- See chapter 19 for defined terms.
Appendix 3Z Page 1
11/3/2002
Appendix 3Z Final Director’s Interest Notice
Part 2 – Director’s relevant interests in securities of which the director is not the registered holder
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
| Name of holder & nature of interestNote: Provide details of the circumstances giving riseto the relevant interestSaintersPtyLtd<Bottomley Super Fund | Number & class of securities800,000 unlisted share optionsexercisable at $0.625 eachexpiring 11May 2021 |
|---|
Part 3 – Director’s interests in contracts
| Detail of contract | N/A |
|---|---|
| Nature of interest | N/A |
| Name of registered holder(if issued securities) | N/A |
| No. and class of securities to whichinterest relates | N/A |
- See chapter 19 for defined terms.
Appendix 3Z Page 2
11/3/2002